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Abstract
Background: To assess the coverage of individual-based primary prevention strategies for cardiovascular disease
(CVD) in Cambodia and Mongolia: specifically the early identification of hypertension and diabetes mellitus, major
proximate physiological CVD risk factors, and management with pharmaceutical and lifestyle advice interventions.
Methods: Analysis of data collected in national cross-sectional STEPS surveys in 2009 (Mongolia) and 2010
(Cambodia) involving participants aged 25-64 years: 5433 in Cambodia and 4539 in Mongolia.
Results: Mongolia has higher prevalence of CVD risk factors than Cambodia –hypertension (36.5% versus 12.3%),
diabetes (6.3% versus 3.1%), hypercholesterolemia (8.5% versus 3.2%), and overweight (52.5% versus 15.5%). The
difference in tobacco smoking was less notable (32.1% versus 29.4%).
Coverage with prior testing for blood glucose in the priority age group 35-64 years remains limited (16.5% in
Cambodia and 21.7% in Mongolia). Coverage is higher for hypertension. A large burden of both hypertension and
diabetes remains unidentified at current strategies for early identification: only 45.4% (Cambodia) to 65.8%
(Mongolia) of all hypertensives and 22.8% (Mongolia) to 50.3% (Cambodia) of all diabetics in the age group 35-64
years had been previously diagnosed.
Approximately half of all hypertensives and of all diabetics in both countries were untreated. 7.2% and 12.2% of
total hypertensive population and 5.9% and 16.1% of total diabetic population in Cambodia and Mongolia,
respectively, were untreated despite being previously diagnosed.
Only 24.1% and 28.6% of all hypertensives and 15.9% and 23.9% of all diabetics in Mongolia and Cambodia,
respectively were adequately controlled. Estimates suggest deficits in delivery of important advice for lifestyle
interventions.
Conclusions: Multifaceted strategies are required to improve early identification, initiation of treatment and
improving quality of treatment for common CVD risk factors. Periodic population-based surveys including questions
on medical and treatment history and the context of testing and treatment can facilitate monitoring of individual-
based prevention strategies.
Background
Non-communicable diseases (NCD) account for a grow-
ing proportion of morbidity and premature mortality
worldwide. This public health problem is neither exclu-
sively nor predominantly associated with high-income
countries (HIC). The total number of NCD-related
deaths is proportionate to the distribution of popula-
tions, with almost 80% occurring in low- and middle-
income countries (LMIC). But this apparent parity
masks the disproportionate impact of NCDs in LMICs.
For example, in 2008, the age-adjusted NCD mortality
rate per 100,000 people was 757 in low-income coun-
tries compared with 380 in HICs [1].
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Cardiovascular disease (CVD) accounts for almost half
of all NCD-related deaths and is the leading cause of
death in the developing world. In LMICs nearly 58% of
CVD deaths are in those under the age of 60 compared
with just 20% in HICs [2]. The increasing CVD burden
largely results from the increased prevalence of modifi-
able risk factors such as tobacco use, unhealthy diets,
limited physical activity, elevated blood cholesterol and
glucose levels and hypertension, which in turn are asso-
ciated with a range of inter-linked social trends: changing
life-styles, dietary habits, occupations, increasing urbani-
zation, globalization and demographic changes [3].
In recent decades, either as part of routine health care or
of specific CVD prevention programs, developed countries
achieved reduction in CVD morbidity and premature mor-
tality through combinations of three strategies: popula-
tion-level primary prevention strategies (intended to
reduce the burden of CVD by reducing overall levels of
modifiable risk factors in the whole population); indivi-
dual-based primary prevention strategies (health service
and advice provision intended to prevent the onset of
CVD through risk factor management in individuals with
established CVD risk factors but no disease); and indivi-
dual-based secondary prevention strategies (health service
provision and advice intended to prevent disease progres-
sion in people with established CVD). Research from sev-
eral countries has consistently shown that reductions in
risk factors explain more of the decline in CVD mortality
than treatments of established disease. Between 42% and
60% of the decline in CVD deaths has been attributed to
changes in risk factors including reduction in total choles-
terol, systolic blood pressure and smoking prevalence,
while 23% to 47% was attributed to treatments and
secondary preventive therapies [4-9]. Population-based
and individual-based primary prevention strategies can
complement one another, both contributing to changes in
risk factors. Their relative contribution is difficult to ascer-
tain, however, and appears to vary in different settings.
While in the US, significant decreases in systolic and dia-
stolic blood pressure among patients with hypertension
between 1988-94 and 2007-08 have been attributed to bet-
ter medical control, changes in dietary habits were consid-
ered a more likely explanation in Finland [9,10]. Regional
variations aside, population and individual changes in
modifiable risk factors can result in relatively rapid
declines in CVD mortality [11].
This paper assesses the coverage of individual-based
primary prevention strategies for CVD. In particular it
considers the early identification and management of
hypertension and diabetes mellitus, which are both major
proximate risk factors for CVD. Recent research has
highlighted very different levels of medical management
of specific CVD risk-factors around the world but little
evidence comes from low-income countries [12,13]. In
addition, there is little evidence on utilization of non-
medical lifestyle interventions as part of targeted primary
prevention strategies. Using nationally representative and
comparable data from two LMICs in Asia, this study
examines the prevalence of CVD risk factors and cover-
age of early detection and management of hypertension
and diabetes mellitus through medical treatment, life-
style modification interventions or both.
Study context
Throughout Asia, demographic and social changes have
resulted in an epidemiological transition, from a total dis-
ease burden dominated by infectious disease to one domi-
nated by NCDs. In many LMICs, this has resulted in a
dual burden of infections diseases and NCDs and in many
health systems are under-resourced and already stretched
[14,15]. Thus both the challenge presented by NCDs and
individual countries’ capacities to address these challenges
vary.
Two LMICs at different stages of transition are consid-
ered in this study. Mongolia, one of the least densely
populated countries in the world with a population of less
than 3 million is a lower-middle-income country with a
growing economy centered on agriculture and mining.
Cambodia, a low-income country of more than 13 million
people, remains largely agricultural and rural [15,16]. In
2008, NCDs were estimated to account for almost 53% of
life years lost in Mongolia, and 31% in Cambodia [1].
Methods
The study uses data from STEPS surveys (STEPwise
Approach to Surveillance) conducted in Cambodia and
Mongolia (Table 1). STEP surveys are similar to
National Health and Nutrition Examination surveys in
wide use in many developed countries such as USA,
Japan and South Korea [17-19]. They are cross-sectional
nationally-representative surveys that combine inter-
views and physical examinations and use standardized
questionnaires and measurement protocols. Aggregated
results of both surveys have been published previously
by internal national bodies [20,21].
Each survey used multi-stage stratified cluster random
sampling to select participants 25-64 years old (15-64
years in Mongolia). Sampled individuals were interviewed
in person to elicit information on selected demographic
and socio-economic characteristics, tobacco and alcohol
use, dietary intake, physical activity, and diagnosis and
treatment history for diabetes and hypertension. The
health examination part comprised of measurements of
height, weight, blood pressure, resting pulse rate, and col-
lection of blood samples. Cholesterol and blood glucose
were measured for the whole sample in Cambodia and
for every third respondent in Mongolia in the age group
25-64 years. For testing of blood glucose, participants
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were instructed to fast for at least 12 hours and not to
consume anything except plain water. Participants on
anti-diabetic medications were advised to refrain from
taking these medications on the morning of the test but
bring the medications with them to take after the testing
was completed. The participants were advised to take any
other medications as usual. Table 1 summarizes the sam-
ple sizes, response rates and measurement methods. All
sampled adults provided written informed consent and
the surveys were approved by National Ethics Committee
for Health Research of Ministry of Health in Cambodia
(number 132 NECHR dated December 4, 2009) and by
the Medical Ethical Committee of the Ministry of Health
in Mongolia (Number 13, dated August.3, 2009) The sur-
vey methodology has been described in detail elsewhere
[20-22].
Outcome variables: definitions
The criteria by which prevalence is calculated for differ-
ent NCD risk factors are presented in Table 2. We also
report estimates of key service provision indicators–level
of prior testing/diagnosis, and treatment as defined
below.
Screening coverage
This indicator provides an estimate of the proportion of
the population that is currently being tested for hyper-
tension or diabetes, whether opportunistic, or in
response to specific symptoms suggestive of hyperten-
sion or diabetes, or as part of a systematic screening
program. The indicator was calculated for 35-64 years
old population, as this group corresponds more closely
with the ages for which guidance suggests screening is
most important [23,24]. The question asked to assess
prior testing was “have you ever had your blood pres-
sure [blood sugar] measured by a doctor or other health
worker?”
Diagnosis coverage
This indicator estimates the proportion of the hyperten-
sive or diabetic population that is aware of their diagno-
sis. It reflects the net outcome of the coverage of
screening and the degree to which this is targeted at
high-risk individuals. The indicator is calculated as the
proportion of total hypertensive (or diabetic) respondents
as identified at the time of survey (using criteria and defi-
nition reported in Table 2) who reported positively to the
question “have you ever been told by a doctor or other
health worker that you have raised blood pressure or
hypertension [blood sugar or diabetes]?”.
Treatment amongst hypertensives and diabetics
Treatment status was elicited by a question: “Are you
currently receiving any of the following treatments/advice
for high blood pressure [diabetes] prescribed by a doctor
or other health worker?” Response categories included
medical treatment - “drugs (medication) that you have
taken in past two weeks” (two separate categories for dia-
betes: insulin and other drugs) - and four non-medical
categories - “advice to reduce salt intake” (“Special pre-
scribed diet” for diabetes), “advice or treatment to lose
weight”, “advice or treatment to stop smoking”, “advice
to start or do more exercise”. The denominator for asses-
sing the treatment coverage includes both total hyperten-
sive and diabetic population identified at the time of
survey (as per the prevalence criteria in Table 2) or those
who self-reported a previous diagnosis. It was considered
important to include participants who self-reported a
previous diagnosis but who were not classified as hyper-
tensive or diabetic by blood pressure or glucose levels or
by medication. This was so that analyses could take into
account previously diagnosed individuals whose raised
blood pressure or blood was managed through non-med-
ical methods. Estimates are reported for the following:
not receiving any treatment (either untreated despite
Table 1 Survey sample sizes, sex and age, response rates and measurement methods
Cambodia Mongolia
Date of data collection Feb - Apr 2010 Oct-Dec 2009
Response rate
Questionnaire 96.3% 95%
Physical measurements 94.2% 95%
Biochemical measurements 92.7% 95%1
Sample size aged (25-64) 5,433 4,539 2
Male: % (95% CI) 48.6 (47.2 - 50.1) 50.3 (48.2 - 52.3)
Age in years: mean (SD) 40.2 (0.20) 39.7 (0.28)
Measurement of Blood pressure (measured
three times in sitting position)
NISSEI Digital Blood Pressure Monitor (Model DS-500) Omron Model 5 Automatic
Blood Pressure Monitor
Measurement of fasting Blood sugar and
cholesterol
Whole capillary blood taken from fingertips; dry chemical
reagent strips & Accutrend GCT instruments
Same as in Cambodia
1 Biochemical measurements were carried out only on one-third of total sampled population in the age group 25-64 years old in Mongolia, and response rate
given here refers to this one-third of the sampled population
2 In Mongolia, the sampled population also included 15-24 years old, but these were excluded for this analysis.
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being previously diagnosed or untreated due to being
undiagnosed prior to survey); currently treated (with the
following subgroups: treated by drugs alone; treated by at
least one of the non-medical treatments described above;
treated or by both drugs and at least one of the non-med-
ical treatments).
Treatment quality deficits
The proportion of the hypertensive (diabetic) population
that reported they were on medication and who had
blood pressure (blood sugar) higher than the diagnostic
threshold at the time of survey was considered an indica-
tor of suboptimal treatment quality. Proportions are also
estimated of those with either condition who are over-
weight, physically underactive or current or previous
smokers but who have not received appropriate advice
about weight loss, exercise or smoking cessation
respectively.
Statistical analysis
All the analyses were conducted using STATA Version
11. Percentages and 95% confidence intervals were cal-
culated for categorical variables. Using the “svy:” func-
tion in STATA, all estimated were weighted to correct
for age-sex variation between samples and target
national populations.
Results
Prevalence of risk factors
Mongolia has significantly higher prevalence of the major
risk factors than Cambodia–hypertension (36.5% versus
12.3%), diabetes (6.3% versus 3.1%), hypercholesterolemia
(8.5% versus 3.2%), and overweight (52.5% versus 15.5%).
The difference in tobacco smoking prevalence was less
notable (32.1% in Mongolia compared to 29.4% in Cam-
bodia). However, Mongolia has a lower proportion of
physical underactive population than Cambodia (6.5%
versus 9.0%) (Table 3).
Screening gap
In both the countries, the proportion of individuals aged
35-64 who reported prior measurement of their blood
pressure was substantially higher than for prior testing
for blood glucose (Table 4). While almost three quarters
of individuals reported previous measurement for blood
pressure in Mongolia, about half of the respondents
reported so in Cambodia. Similarly, the proportion of
individuals whose blood glucose was previously mea-
sured was lower in Cambodia (16.5%) compared to
21.7% in Mongolia.
Diagnosis gap
Consistent with higher screening coverage, proportions
of total hypertensive individuals who were previously
diagnosed were much higher in Mongolia (65.8%) com-
pared to Cambodia (45.4%). However, despite the lower
screening coverage for blood sugar in Cambodia, a signif-
icantly higher proportion of total diabetic individuals in
Cambodia reported being previously diagnosed (50.3%)
than in Mongolia (22.8%), which may suggest better tar-
geting of testing to high-risk individuals in Cambodia
(Table 4).
Management of hypertension and diabetes
Approximately half of the total hypertensive population
in both countries, was untreated, though the proportion
was higher in Cambodia (57.8%) than in Mongolia
(47.2%) (Table 5). Of the total hypertensive population,
7.2% in Cambodia and 12.2% in Mongolia were untreated
despite being previously diagnosed, 50.6% and 35.0%
were untreated due to being undiagnosed. In Cambodia
13.8% and in Mongolia 17.0% of hypertensives received
non-medical treatments alone while 22.9% and 21.3%
received both medical and non-medical treatments. At
14.6% the proportion receiving medical treatment alone
was much greater in Mongolia than in Cambodia (5.4%).
Table 2 Criteria used to define and calculate prevalence of risk factors
Risk factor variable Definition/numerator Denominator
Diabetes prevalence Respondents with survey-measured fasting blood glucose ≥ 6.1 mmol/l/110
mg/dl (whole blood); or measurement below threshold but respondent
reporting insulin or other medication.
All respondents aged 25-64 with biochemical
measurements at time of survey
Hypertension
prevalence
Respondents with systolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg diastolic; or measurements below thresholds but
respondent reporting anti-hypertensive medication.
All respondents aged 25-64 with




Measurement of total cholesterol ≥ 6.2 mmol/l (240 mg/dl) at the time of
survey; or measurement below threshold but currently on medication for
raised cholesterol.
All respondents aged 25-64 with
measurement of blood cholesterol at the time
of survey
Physically underactive Physical inactivity assessed to be < 600 MET (metabolic equivalent) minutes
per week as per the Global Physical Activity Questionnaire (GPAQ) scoring
protocol[22,25,26].
All respondents aged 25-64 years
Overweight Body Mass Index ≥ 25 kg/m2. All aged 25-64 years with height and weight
measured (pregnant women excluded)
Current smoking Respondents reporting positively to question “do you currently smoke any
tobacco product such as cigarettes, cigars, or pipes”
All respondents aged 25-64 years
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Slightly more than half of the total diabetic population
in each country reported being untreated: 52.0% in
Cambodia and 53.3% in Mongolia. In Mongolia nearly a
third of these (16.1/53.4)were untreated despite previous
diagnosis. This was the case for only one eighth (5.9/
52.0)of untreated diabetics in Cambodia. At 25.8% the
proportion of those receiving non-medical treatment
alone in Mongolia was markedly higher than in Cambo-
dia (9.9%) (Table 5).
Only around a quarter (28.6% and 24.1%) of the total
hypertensive population and less than a quarter (23.9%
and 15.9%) of the total diabetic population in Cambodia
and Mongolia, respectively, had blood pressure or blood
sugar levels that were controlled and less than the diag-
nostic thresholds upon survey measurement, including
those on current medication.
Treatment quality deficits
More than two-thirds of hypertensive individuals receiv-
ing medications in Mongolia, and one-third in Cambodia
had inadequately controlled blood pressure. Point esti-
mates suggest deficits in delivery of key health advice to
hypertensive individuals who are smokers, overweight or
obese or physically underactive, but the small numbers
included in analyses in many instances undermine the
strength of these findings. Levels of uncontrolled blood
glucose in diabetics on medication and poor advice levels
among high-risk diabetic subgroups appear also to be of
concern, but again low numbers of cases are available for
analyses (Table 6).
Discussion
Using nationally representative data, this study
assessed coverage of individual-based primary preven-
tion strategies involving early detection and manage-
ment of risk factors for CVD in two LMIC countries
in Asia.
The study revealed key CVD risk factors already at
alarming levels, with hypertension in particular emer-
ging as a major public health concern. This high preva-
lence of risk factors warrants aggressive population-wide
strategies such as public awareness campaigns and
appropriate legislation and policy measures to alter soci-
etal norms relating to dietary salt intake, tobacco smok-
ing and physical inactivity [27]. Individual-based primary
prevention using medical and non-medical measures to
Table 3 Prevalence of cardiovascular risk factors in population aged 25-64 in Cambodia and Mongolia
Risk factor Cambodia Mongolia
Number included in analysis Value
[95% CI]
Number included in analysis Value
[95% CI]
P-value (chi2 Pearson test)




































Table 4 Screening and diagnosis coverage for hypertension and diabetes in 35-64 years old population
Cambodia Mongolia
Number included in analysis Value (%)
95% CI
Number included in analysis Value (%)
95% CI
Hypertension
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reduce risk factors in high-risk persons also needs to be
scaled-up to complement population-wide measures.
Timely detection of underlying risk factors, a critical
component of the individual-based primary prevention
strategies, emerged as a major challenge. No formal guide-
lines for universal, targeted or opportunistic screening for
CVD risk factors existed at the time of the surveys in both
countries, though both prioritize early detection of NCDs
in current national policy and program documents
[16,28-30].
The results suggest that an improved proportion of cases
might be detected by targeted testing. For example, while
in Cambodia only 16.5% of 35-64 year old population
reported previous testing for blood sugar and yet 50.3% of
total diabetic cases were previously diagnosed. Indeed, uni-
versal screening may not be feasible in many LMIC: evi-
dence-based guidelines for opportunistic screening of
high-risk population groups as identified based on
epidemiological profile may be the first step, although
poor overall health service utilization may limit coverage
[31,32]. The frequent co-existence in individuals of several
risk factors justifies strategies/guidelines for concurrent
screening for multiple risk factors, an approach that also
allows assessment of the absolute global risk of developing
CVD in the next five to ten years–the recommended
approach for making treatment decisions as discussed
later [33].
The treatment gap in each country comprises those who
are untreated because they are as yet undiagnosed, plus
the proportion of individuals who are untreated despite
previous diagnosis. In the absence of any follow-up ques-
tions, it is hard to identify the reasons for lack of treatment
in these previously diagnosed hypertensives and diabetics,
which may be both supply and demand related: due to fac-
tors related to difficulties in accessing or paying for treat-
ment, and in some cases personal attitudes or preferences.
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Total diabetic sample (N)* (208) (175)
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* Includes both survey-measured and self-reported
† Figures were rounded from five decimal points STATA outputs to one decimal point for the table. The sum of multiple rounded figures in the table may not
exactly equal 100%.
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A substantial treatment gap amongst the previously diag-
nosed population suggests that any plans to improve early
diagnosis must be accompanied by increased provision,
accessibility and affordability of treatment.
Approximately 14% and 17% of total of population with
raised blood pressure and 10% and 26% of diabetics in
Cambodia and Mongolia, respectively, reported receiving
non-medical treatment alone. Such high proportions may
reflect national guidelines that encourage utilization of
non-medical lifestyle treatments in patients below recom-
mended thresholds for initiation of medical treatments.
But they may also in part reflect the reliance on non-
medical therapies in a subgroup of patients who cannot
afford or access medical treatments.
Although guidance on diagnostic thresholds for initiating
medical treatment may vary, non-medical interventions are
recommended in all individuals at the diagnostic threshold
used in this study [33,34]. In Mongolia 14% of hyperten-
sives reported receiving medical, but no non-medical treat-
ments raising concerns about clinical practice. It appears
that appropriate lifestyle advice that can improve manage-
ment is not reaching many of these people.
The results suggest that diagnosis or initiation of treat-
ment does not ensure effective disease management.
Point estimates indicate worrisome levels of uncontrolled
blood pressure and blood glucose among people on treat-
ment and poor life-style advice levels amongst subgroups
especially in need.
Implications for service development
Our findings for diagnosis gap and treatment coverage and
quality are in line with other research that has drawn
attention to suboptimal diagnosis and management of
NCD risk factors. For example, some 70% of diabetics in
seven countries in Europe, Asia and North and South
America were assessed as failing to attain recommended
blood sugar levels [12,13]. To reduce CVD mortality, a key
goal of primary prevention strategies is to achieve a rea-
sonable level of control of these risk factors. For example,
one of the national objectives under Healthy People 2010
initiative in USA includes controlling blood pressure in
50% of all individuals with hypertension [10].
This study suggests that in Cambodia and Mongolia
only about a quarter of all hypertension and less than a
quarter of all diabetes is adequately controlled. Thus
improvement in primary prevention strategies will require
multifaceted efforts to improve detection and diagnosis,
treatment of those diagnosed, and the quality of treatment
among those who are treated In addition, our findings
suggest improvements can be made in optimal use of non-
medical therapies.
Finally, the very high prevalence of risk factors as
defined at the cut-offs levels used for each risk factor
may imply need for substantial increase in health finan-
cing to provide drug treatment. Global absolute CVD
risk assessment based on levels of multiple risk factors
may be used to prioritize people with higher overall CVD
risk for drug treatment, while those with lower overall
risk may be followed-up with systematic life-style inter-
ventions. WHO and International Society for Hyperten-
sion has published cardiovascular risk prediction charts
for all the fourteen WHO epidemiological sub-regions
that can be used by physicians or non-physicians in low-
resource settings to estimate 10-year risk of a fatal or
Table 6 Specific treatment quality deficits in management of hypertension and diabetes
Cambodia Mongolia
Indicator Number included in analysis Value %
(95% CI)
Number included in analysis Value%
(95% CI)
Hypertension
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non-fatal cardiovascular event [33]. Recent research has
suggested this approach offers substantial cost-saving in
drug treatments [35]. Appropriate screening strategies
will still be required for early identification of people
with moderate to high absolute global CVD risk, but to
date none of the countries have formally introduced clin-
ical guidelines either for screening or treatment based on
absolute CVD risk assessment, though Mongolia is in the
process of developing these guidelines.
Limitations
The study has limitations that must be acknowledged.
For example, due to the surveys’ cross-sectional nature,
whereas guidelines recommend that diagnosis should
only be made on the basis of raised blood pressure sus-
tained over time, the study diagnoses of hypertension are
based upon multiple measurements at a single visit and
thus may not be sufficient for a confirmed diagnosis or to
assess the adequacy of control in individuals [16]. There
may be inter-investigator variations in measurement that
were not assessed in the survey and hence were not
taken into account. The advice to refrain from the taking
of diabetes medications on the morning of the blood
tests may have delayed medication for some hours and
affected readings in some participants. Adherence these
and to fasting instructions is unknown. While the litera-
ture is consistent on suitability of capillary whole blood
for screening of diabetes in population based surveys, the
cut-off used to diagnose diabetes for capillary blood ver-
sus venous plasma is still debatable [23,36]. In the
absence of any clear national guidelines in either of these
countries, we used the most-commonly used cut-offs
reported in international literature and guidelines. Mea-
sures of prevalence, diagnosis and treatment gap will vary
greatly based on the diagnostic cut-off for hypertension
and diabetes,, though this methodology will still be
appropriate to assess the trends in these indicators over
time if similar measurement methods and diagnostic cut-
offs are used. Finally, the study does not capture the
complete disease burden that health systems may face,
due to exclusion of population aged over 65, which may
have much higher disease burden.
Implications for future surveys/research to monitor
response to NCDs
With regards to self-report of previous testing, it was
not possible to ascertain whether individuals were
tested previously as part of formal, opportunistic or
universal screening programs or were simply tested
when they sought services on experiencing symptoms.
Nor can the source of testing be discerned: whether
public or private or whether in primary or secondary
care. Inclusion of questions on context of testing in
future surveys may help to evaluate early detection
strategies as more countries scale up NCD early diag-
nosis and care programs. Additional questions on
adherence to treatment, cost and affordability of treat-
ment and source of treatment may be included to dis-
tinguish and estimate the demand and supply-side
factors affecting the treatment coverage. We were
unable to examine the primary prevention of hyperch-
olesterolemia due to lack of medical history for prior
diagnosis and treatment. Considering the prominence
given to high cholesterol levels in determining absolute
CVD risk, the medical history for hypercholesterolemia
may be included in future surveys.
Conclusions
The prevalence of risk factors for CVD is already at
alarming levels in both countries. Only a small propor-
tion of the total hypertensive or diabetic populations
have adequately controlled blood pressure or blood
sugar due to large diagnosis gap, non-treatment of pre-
viously diagnosed populations and inadequate control of
treated population. Aggressive population-wide strate-
gies complemented by individual-based primary preven-
tion strategies will be required. Guidelines for
concurrent screening of multiple risk factors in targeted
population groups as identified based on epidemiological
profile, which can be realistically delivered by health sys-
tems in these poorly resourced setting will be needed.
Prioritization of individuals based on global CVD risk
for drug treatment may reduce the overall cost of treat-
ment. Non-medical treatment needs to be emphasized
equally. Periodic population-wide surveys including
questions on adherence to the treatment, reasons for
not-seeking treatment, source and cost of the treatment,
etc. should be conducted to better inform the programs
and to monitor the performance of these efforts.
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